Search
for
Sort by
Research 481–510 of 1000+
- Morphea: progress to date and the road ahead
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Microneedling for Cutaneous Manifestations of Autoimmune Disease: A Scoping Review
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- Adipose Tissue‐Derived Exosomes in the Treatment of Lichen Planopilaris: A Case Report
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Evaluation of the Awareness, Beliefs, and Psychological Impact of Patients with Alopecia Areata in Makkah City, Saudi Arabia
- Effect of fractional laser alone or in combination on alopecia areata: A systematic review and meta‐analysis
- Overview of the Role of 308 Monochromatic Excimer Phototherapy for the Treatment of Alopecia Areata
- Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A systematic review
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- JAK Inhibitors for Treatment of Alopecia Areata
- Immunomodulatory Potential and Biocompatibility of Chitosan–Hydroxyapatite Biocomposites for Tissue Engineering
- Efficacy of diphenylcyclopropenone in alopecia areata: a comparison of two treatment regimens
- Treatment of Satoyoshi syndrome: a systematic review
- Myasthenia Gravis Coexisting With Primary Sjögren's Syndrome: Report of Three Cases and Literature Review
- Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Mesenchymal Stem Cells for the Treatment of Skin Diseases
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- Screening of dermatology drugs for aberrant use‐patterns: An application of epidemiologic estimates and measures of inequality in drug use